ProfileGDS5822 / ILMN_2552202
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 3% 27% 4% 7% 44% 9% 35% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 16.53
GSM1276600PDAC Late Ablation Control 216.627
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 16.84
GSM1276603PDAC Late Ablation 2
GSM1276604PDAC Late Ablation 36.87
GSM1303940PDAC Late Ablation_anti-CTLA4 119.844
GSM1303941PDAC Late Ablation_anti-CTLA4 26.29
GSM1303942PDAC Late Ablation_anti-CTLA4 316.935